Analgesic Effect of Oxytocin Receptor Modulation

NCT01918475 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Pain
Hyperalgesia
Central Sensitization

Interventions

DRUG: Carbetocin
DRUG: Placebo

Sponsor

Insel Gruppe AG, University Hospital Bern